Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: A prospective study from the French society of bone marrow transplantation and cell therapy

Journal of Clinical Oncology

Volumn 24, Issue 36, 2006, Pages 5695-5702

  Yakoub Agha, Ibrahim ^a   Mesnil, Florence ^a   Kuentz, Mathieu ^a   Boiron, Jean Michel ^a   Ifrah, Norbert ^a   Milpied, Noel ^a   Chehata, Sami ^a   Esperou, Helene ^a   Vernant, Jean Paul ^a   Michallet, Mauricette ^a   Buzyn, Agnes ^a   Gratecos, Nicole ^a   Cahn, Jean Yves ^a   Bourhis, Jean Henri ^a   Chir, Zina ^a   Raffoux, Colette ^a   Socié, Gerard ^a   Golmard, Jean Louis ^a   Jouet, Jean Pierre ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; METHOTREXATE;

ACUTE LEUKEMIA; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ALLELE; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INTERSTITIAL PNEUMONIA; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SEROLOGY; SIBLING; TREATMENT OUTCOME; ALLOTRANSPLANTATION; BLOOD DISEASE; HISTOCOMPATIBILITY TEST; STEM CELL TRANSPLANTATION; SURVIVAL;

ADULT; FEMALE; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; PROSPECTIVE STUDIES; SIBLINGS; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 34247163959     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.08.0952     Document Type: Article

References (37)

1. Armitage JO: Bone marrow transplantation. N Engl J Med 330:827-838, 1994
2. Hunault M, Harousseau JL, Delain M, et al. Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: A GOELAMS trial. Blood 104:3028-3037, 2004
3. Martino R, Caballero MD, Simon JA, et al: Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes. Blood 100:2243-2245, 2002
4. Sanders JE, Im HJ, Hoffmeister PA, et al: Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia. Blood 105: 3749-3756, 2005
5. Suciu S, Mandelli F, de Witte T, et al: Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AMD in first complete remission (CRD: An intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial. Blood 102:1232-1240, 2003
6. Yakoub-Agha I, de La Salmoniere P, Ribaud P, et al: Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: A long-term study of 70 patients-report of the French Society of Bone Marrow Transplantation. J Clin Oncol 18:963-971, 2000
7. Petersdorf EW, Gooley TA, Anasetti C, et al: Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 92:3515-3520, 1998
8. Petersdorf EW, Malkki M: Human leukocyte antigen matching in unrelated donor hematopoietic cell transplantation. Semin Hematol 42:76-84, 2005
9. Flomenberg N, Baxter-Lowe LA, Confer D, et al: Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 104:1923-1930, 2004
10. Petersdorf EW, Kollman C, Hurley CK, et al: Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: The US National Marrow Donor Program Experience. Blood 98:2922-2929, 2001
11. Petersdorf EW, Longton GM, Anasetti C, et al: Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 89:1818-1823, 1997
12. Petersdorf EW, Smith AG, Mickelson EM, et al: The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 81: 1923-1932, 1993
13. McGlave P, Scott E, Ramsay N, et al: Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia. Blood 70:877-881, 1987
14. Ottinger HD, Ferencik S, Beelen DW, et al: Hematopoietic stem cell transplantation: Contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood 102:1131-1137, 2003
15. Weisdorf DJ, Anasetti C, Antin JH, et al: Allogeneic bone marrow transplantation for chronic myelogenous leukemia: Comparative analysis of unrelated versus matched sibling donor transplantation. Blood 99:1971-1977, 2002
16. Cornelissen JJ, Carston M, Kollman C, et al: Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: Strong graft-versus-leukemia effect and risk factors determining outcome. Blood 97:1572-1577, 2001
17. Cornillon J, Fawaz A, Depil S, et al: Outcome of patients less than 55 years of age with high-risk acute leukemia who did not have an human leukocyte antigen-identical related donor: A long-term study of 97 consecutive patients. Leuk Lymphoma 46:841-849, 2005
18. Sierra J, Storer B, Hansen JA, et al: Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: The effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 89:4226-4235, 1997
19. Petersdorf EW, Anasetti C, Martin PJ, et al: Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 104:2976-2980, 2004
20. Zander AR, Kroger N, Schleuning M, et al: ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML). Bone Marrow Transplant 32:355-361, 2003
21. Sierra J, Radich J, Flansen JA, et al: Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 90:1410-1414, 1997
22. Marsh SG, Bodmer JG, Albert ED, et al: Nomenclature for factors of the HLA system, 2000. Tissue Antigens 57:236-283, 2001
23. Przepiorka D, Weisdorf D, Martin P, et al: 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15:825-828, 1995
24. Cox D: Regression models and life tables (with discussion). J R Stat Soc 34:187-220, 1972
25. Kaplan E, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
26. Kalbfleisch J, Prentice R: The statistical analysis of failure time data. New York, NY, Wiley, 1980
27. Brunet S, Esteve J, Berlanga J, et al: Treatment of primary acute myeloid leukemia: Results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy. Haematologica 89:940-949, 2004
28. Giralt S: Bone marrow transplant in myelodysplasia syndromes: New technologies, same questions. Curr Hematol Rep 3:165-172, 2004
29. Guardiola P, Runde V, Bacigalupo A, et al: Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. Blood 99:4370-4378, 2002
30. Neudorf S, Sanders J, Kobrinsky N, et al: Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival. Blood 103: 3655-3661, 2004
31. Schmitz N, Beksac M, Hasenclever D, et al: Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 100:761-767, 2002
32. Thomas X, Boiron JM, Huguet F, et al: Outcome of treatment in adults with acute lymphoblastic leukemia: Analysis of the LALA-94 trial. J Clin Oncol 22:4075-4086, 2004
33. Anasetti C, Amos D, Beany PG, et al: Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 320:197-204, 1989
34. Leisenring WM, Martin PJ, Petersdorf EW, et al: An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens. Blood 108:749-755, 2006
35. Shaw BE, Marsh SG, Mayor NP, et al: HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood 107:1220-1226, 2006
36. Meijer E, Dekker AW, Rozenberg-Arska M, et al: Influence of cytomegalovirus seropositivity on outcome after T cell-depleted bone marrow transplantation: Contrasting results between recipients of grafts from related and unrelated donors. Clin Infect Dis 35:703-712, 2002
37. Patel SR, Ridwan RU, Ortin M: Cytomegalovirus reactivation in pediatric hemopoietic progenitors transplant: A retrospective study on the risk factors and the efficacy of treatment. J Pediatr Hematol Oncol 27:411-415, 2005